Morgan Stanley
NBTX

Morgan Stanley’s Nanobiotix NBTX Stock Holding History

Morgan Stanley’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
49,789
+13,515
+37% +$503K ﹤0.01% 4888
2026
Q1 		$1.12M Buy
36,274
+13,351
+58% +$352K ﹤0.01% 5076
2025
Q4 		$530K Buy
22,923
+20,545
+864% +$449K ﹤0.01% 5482
2025
Q3 		$44.9K Sell
2,378
-2,922
-55% -$24.9K ﹤0.01% 6444
2025
Q2 		$25.1K Sell
5,300
-800
-13% -$3.1K ﹤0.01% 6579
2025
Q1 		$21.8K Buy
6,100
+998
+20% +$3.45K ﹤0.01% 6544
2024
Q4 		$14.6K Buy
5,102
+5,100
+255,000% +$20.4K ﹤0.01% 6671
2024
Q3 		$12 Hold
2
– – ﹤0.01% 7856
2024
Q2 		$10 Hold
2
– – ﹤0.01% 7779
2024
Q1 		$13 Sell
2
-602
-100% -$4.26K ﹤0.01% 7753
2023
Q4 		$4.4K Sell
604
-1,096
-64% -$6.95K ﹤0.01% 7027
2023
Q3 		$14.9K Buy
+1,700
New +$14.1K ﹤0.01% 6577
2021
Q4 		– Sell
-300
Closed -$3K – 8058
2021
Q3 		$3K Hold
300
– – ﹤0.01% 7602
2021
Q2 		$4K Hold
300
– – ﹤0.01% 7447
2021
Q1 		$5K Sell
300
-11,190
-97% -$192K ﹤0.01% 7109
2020
Q4 		$190K Buy
+11,490
New +$198K ﹤0.01% 5617

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Morgan Stanley's NBTX Position: Q2 2026 in Review

Morgan Stanley increased its Nanobiotix (NBTX) stake by 37% in Q2 2026, buying an estimated $503K and bringing the position to 49,789 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #4888.

Morgan Stanley first reported a position in NBTX in Q4 2020 and has held it in 16 quarters since. 12 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • Morgan Stanley held 49,789 shares of Nanobiotix worth $1.88M as of Q2 2026.
  • Morgan Stanley bought 13,515 Nanobiotix shares in Q2 2026, an estimated $503K.
  • Nanobiotix made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4888 holding.
  • Morgan Stanley first reported a position in Nanobiotix in Q4 2020 and has held it in 16 quarters since.
  • 12 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.